KYNB
Kyntra Bio, Inc. Common Stock
KYNB • NASDAQ
Kyntra Bio, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Thane Wettig, with a market cap of $26.7M.
CEOThane Wettig
Market Cap$26.7M
PHARMACEUTICAL PREPARATIONS
Next Earnings
Upcoming earnings announcement for Kyntra Bio, Inc. Common Stock
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$3.36
Revenue Estimate
$1.6M
Earnings History
Past 1 earnings report for Kyntra Bio, Inc. Common Stock
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$3.61Est: -$3.89 | +7.2% | $1.3MEst: $1.6M | -20.8% |  10-K |